| SOLENO THERAPEUTICS INC |
10%+ Owner |
Common Stock |
18,022,602 |
$657,560,041 |
$36.49 |
29 Mar 2022 |
Indirect |
| Jasper Therapeutics, Inc. |
10%+ Owner |
Common Stock |
5,628,558 |
$119,473,461 |
$21.23 |
24 Sep 2021 |
By Abingworth Bioventures VII, LP |
| Sierra Oncology, Inc. |
10%+ Owner |
Common Stock, $0.001 par value |
1,314,127 |
$72,276,985 |
$55.00 |
31 Jan 2022 |
Indirect |
| Vera Therapeutics, Inc. |
10%+ Owner |
Class A Common Stock |
2,960,231 |
$53,284,158 |
$18.00 |
18 May 2021 |
Indirect |
| eFFECTOR Therapeutics, Inc. |
10%+ Owner |
Common Stock |
4,822,114 |
$2,924,612 |
$0.6065 |
25 Aug 2021 |
Indirect |
| SOLENO THERAPEUTICS INC |
10%+ Owner |
Warrant (right to buy) |
7,720,000 |
|
|
29 Mar 2022 |
Indirect |
| Jasper Therapeutics, Inc. |
10%+ Owner |
Stock Option (right to buy) |
78,045 |
|
|
21 Mar 2022 |
Indirect |
| eFFECTOR Therapeutics, Inc. |
10%+ Owner |
Stock Option (right to buy) |
40,000 |
|
|
06 Oct 2021 |
Indirect |
| SOLENO THERAPEUTICS INC |
10%+ Owner |
Stock Option (right to buy) |
31,862 |
|
|
01 Jun 2021 |
Indirect |
| Vera Therapeutics, Inc. |
10%+ Owner |
Stock Option (right to buy) |
9,925 |
|
|
13 May 2021 |
Indirect |
| Sierra Oncology, Inc. |
10%+ Owner |
Series B Warrants (right to buy) |
0 |
|
|
28 Jan 2022 |
Indirect |